Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision label updated from v3.3.1 to v3.3.2. Substantive study content such as the title, eligibility criteria, interventions, and locations remains unchanged.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded a PubMed auto-fill note and a new revision tag (v3.3.1) while removing the older PubMed note and revision tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedThe government funding/status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check38 days agoChange DetectedThe two screenshots depict the same study details page with no changes to the core information (title, conditions, interventions, inclusion/exclusion criteria, enrollment, or locations).SummaryDifference0.4%

- Check68 days agoChange DetectedUpdate: the page version is updated from v3.0.2 to v3.2.0. No other content changes detected.SummaryDifference0.1%

- Check69 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.